ArticleDrugs - real world outcomes2022

Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).

Ying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.